Back to search

Netherlands· NL-1c84cd6f0b45

Carmustine Glenmark 100 mg, poeder en oplosmiddel voor concentraat voor oplossing voor infusie

A carmustine product containing carmustine, registered in Netherlands by Glenmark Arzneimittel GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC L01AD01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCarmustine Glenmark 100 mg, poeder en…ATCL01AD01REGISTER NO.NL-1c84cd6f0b45PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Carmustine is registered in 16 of 19 countries.

Countries holding a registration under ATC L01AD01 (carmustine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Carmustine · ATC L01AD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CARMUSTINE
Manufacturer
Glenmark Arzneimittel GmbH
Country
Netherlands (NL)
ATC code
L01AD01
ATC class
Carmustine
Defined daily dose
8.57 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    123151

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

253 interactions on record for carmustine.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Carmustine · interactions on record

253 records

  • 36 severe
  • 108 moderate
  • 15 minor
  • 94 info

Most severe, free to view

  • CimetidineA02BA01severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Nalidixic acidJ01MB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Carmustine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carmustine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Carmubris®, Carmustin Accord
  • Belgium · Carmustine Tillomed
  • Cyprus · Carmustine Accord, Carmustine Msn
  • Czechia · Carmustine Accord, Carmustine Msn
  • Germany · Carmubris, Carmustin Accord
  • Denmark · Carmustin Waymade, Carmustine Accord
  • Estonia · Carmustine Accord
  • Spain · Bicnu, Carmustina Accord
  • Finland · Carmustine Accord, Carmustine Accordpharma
  • France · Bicnu, Carmustine Accord
  • United Kingdom (Northern Ireland) · Carmustine Accord, Carmustine Accord Healthcare
  • Greece · Carmustine Tillomed, Carmustine Waymade
  • Croatia · Karmustin Msn, Karmustin Pliva
  • Hungary · Carmustine Teva, Carmustine Tillomed
  • Ireland · Carmustine Accord, Carmustine Accord Healthcare Ireland
  • Iceland · Carmustine Medac, Carmustine Stada
  • Italy · Bicnu, Carmustina Hikma
  • Liechtenstein · Carmustin Medac
  • Lithuania · Carmustine Zentiva
  • Malta · Carmustine Dr. Reddys
  • Norway · Carmustine, Carmustine Accord
  • Poland · Carmustine Accord, Carmustine Accordpharma
  • Portugal · Carmustina Accord, Carmustina Accordpharma
  • Romania · Carmustină Waymade
  • Sweden · Carmustine, Carmustine Accord
  • Slovenia · Karmustin Teva, Karmustin Tillomed Pharma
  • Slovakia · Carmustine Zentiva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c7f56345-0fff-4d58-acac-1eb71a486d8c
GET /v1/drugs/c7f56345-0fff-4d58-acac-1eb71a486d8c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123151_smpc.pdf",
  "strength": null,
  "atc_label": "Carmustine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123151",
  "excipients": [
    "GEEN HULPSTOFFEN",
    "PROPYLEENGLYCOL (E 1520)"
  ],
  "substances": [
    "CARMUSTINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123151.pdf",
  "authorised_at": "2019/08/15",
  "procedure_number": "NO/H/0289/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "123151",
  "additional_monitoring": "N"
}

See everything about carmustine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.